Andy Fanning is Co-Founder and CEO of Optura.ai, the enterprise healthcare platform purpose-built to deliver ROAI (Return on AI Investment), helping payers, providers, and life sciences organizations move from scattered AI pilots to measurable, production-ready outcomes.

Andy attended William Woods University and spent years at Cigna leading business transformation and AI strategy, rising to Vice President at Evernorth, where he developed deep expertise in healthcare operations and AI adoption.

Andy co-founded Optura with Michael Hollis after witnessing firsthand the gap between AI ambition and real ROI in healthcare, pioneering the trademarked ROAI framework as a design principle, not just a metric.

Under Andy's leadership, Optura raised a $6.5M seed round co-led by Susa Ventures and Matrix Partners, followed by a $17.5M Series A led by Salesforce Ventures with participation from Echo Health Ventures, bringing total funding to over $25M.

Optura's platform now hosts over $2B in healthcare AI initiatives, has tracked $120M in value at a 700% ROAI on active initiatives, and serves enterprise clients including Independence Blue Cross, Prime Therapeutics, and Ardent Health.